Cullinan Therapeutics, Inc.

VOYA INVESTMENT MANAGEMENT LLC CGEM

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/12/2026

Shares

11,815

Value ($000)

215

Weight

0.0%

2021 Q1 - 2026 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/12/2026	215	0.0%	11,815	6/30/2026
2025 Q2	8/14/2025	110	0.0%	14,661	6/30/2025
2025 Q1	5/15/2025	109	0.0%	14,397	3/31/2025
2024 Q4	5/2/2025	186	0.0%	15,277	12/31/2024
2024 Q3	2/7/2025	268	0.0%	16,010	9/30/2024
2024 Q2	2/7/2025	226	0.0%	12,969	6/30/2024
2023 Q4	2/7/2025	103	0.0%	10,061	12/31/2023
2023 Q3	2/7/2025	97	0.0%	10,754	9/30/2023
2023 Q2	2/7/2025	116	0.0%	10,754	6/30/2023
2023 Q1	2/7/2025	126	0.0%	12,281	3/31/2023
2022 Q4	2/7/2025	130	0.0%	12,281	12/31/2022
2022 Q3	2/7/2025	157	0.0%	12,281	9/30/2022
2022 Q2	8/15/2022	144	0.0%	11,209	6/30/2022
2021 Q3	11/15/2021	215	0.0%	9,518	9/30/2021
2021 Q1	5/17/2021	228	0.0%	5,466	3/31/2021